COVID-19 Stroke on Russia: Looking Forward for Future Development through Antibody Test Spectacles

Brief communication

Natalia P. Sharova,                            

PhD, Dr habil (Biology), Deputy Director of N. K. Koltsov Institute of Developmental Biology of Russian Academy of Sciences, Head of Laboratory of Biochemistry of Ontogenesis Processes, Russia

Address: N. K. Koltsov Institute of Developmental Biology of Russian Academy of Science, Vavilova st 26, Moscow, 119334, Russia

E-mail: npsharova@bk.ru 

Article ID: 011270018

Published online: 2 July 2020

HANDLE: https://hdl.handle.net/20.500.12656/thebeacon.3.011270018

DOI: https://doi.org/10.55269/thebeacon.3.011270018

 

Quoting (Chicago style): Sharova, Natalia P. 2020. “COVID-19 stroke on Russia: Looking forward for future development through antibody test spectacles.” The Beacon: Journal for Studying Ideologies and Mental Dimensions 3, 011270018. https://doi.org/10.55269/thebeacon.3.011270018

Language: English



Download the full text:

Vol. 1 No. 1 Pdf


Download high-resolution images:

Figure 1          Figure 2

  

Abstract

On 9 June 2020, COVID-19-related quarantine measures were at last suspended in Moscow. Russian government claimed that an effective tool to predict future post-COVID-19 development of Russia would be mass screening of Russian population for antibodies to SARS-CoV-2. However, analysing the techniques used by Moscow and several other Russian local authorities to detect antibodies, we come to a conclusion that such screening is being performed ineffectively. An alternate has been proposed in the paper.

Key words: SARS-CoV-2, antibody test, mass screening, population screening, herd immunity, post-COVID social development

© 2020 Natalia P. Sharova.
Licensee The Beacon: Journal for Studying Ideologies and Mental Dimensions.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) that permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

CC Licence

Return to the issue


go to